Skip to content
TYBR Health logo

TYBR Health

TYBR Health is a YC Winter 2022 (W22) company. Based in Houston, TX, USA. Team of 3.

  • B2B
  • Medical Devices

About TYBR Health

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

TYBR Health develops the B3 Gel System, a flowable, naturally derived hydrogel that surgeons apply directly to tendons and ligaments at the close of repair surgery. The gel creates a protective barrier around healing tissue during the critical post-operative window, preventing the restrictive scar formation that limits mobility in a significant share of tendon repair patients. It replaces the absence of any targeted anti-scarring intervention at the surgical site, addressing a gap that traditional barriers leave open.

Go-to-market

Orthopedic and hand surgeons are the direct buyers, adopting the B3 Gel System as a point-of-care adjunct applied intraoperatively at the end of tendon or ligament repair procedures.

From the Y Combinator listing

How TYBR Health describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Natural hydrogel to keep internal organs scar-free after surgery

TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
Houston, TX, USA
Team size
3
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works